Ultrasmall Gold Nanoparticles Behavior in Vivo Modulated by Surface Polyethylene Glycol (PEG) Grafting.

Ultrasmall nanoparticles provide us with essential alternatives for designing more efficient nanocarriers for drug delivery. However, the fast clearance of ultrasmall nanoparticles limits their application to some extent. One of the most frequently used compound to slow the clearance of nanocarriers and nanodrugs is PEG, which is also approved by FDA. Nonetheless, few reports explored the effect of the PEGylation of ultrasmall nanoparticles on their behavior in vivo. Herein, we investigated the impact of different PEG grafting level of 2 nm core sized gold nanoparticles on their biological behavior in tumor-bearing mice. The results indicate that partial (∼50%) surface PEGylation could prolong the blood circulation and increase the tumor accumulation of ultrasmall nanoparticles to a maximum extent, which guide us to build more profitable small-sized nanocarriers for drug delivery.

[1]  Vincent M. Rotello,et al.  Fully Zwitterionic Nanoparticle Antimicrobial Agents through Tuning of Core Size and Ligand Structure. , 2016, ACS nano.

[2]  Sumaira Ashraf,et al.  In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.

[3]  N. Hampp,et al.  Basic Physicochemical Properties of Polyethylene Glycol Coated Gold Nanoparticles that Determine Their Interaction with Cells. , 2016, Angewandte Chemie.

[4]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[5]  S. Hou,et al.  The Interplay of Size and Surface Functionality on the Cellular Uptake of Sub-10 nm Gold Nanoparticles. , 2015, ACS nano.

[6]  Raimo Hartmann,et al.  In vivo integrity of polymer-coated gold nanoparticles. , 2015, Nature nanotechnology.

[7]  Raimo Hartmann,et al.  Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.

[8]  Dong Choon Hyun,et al.  Engineered nanoparticles for drug delivery in cancer therapy. , 2014, Angewandte Chemie.

[9]  En-Wei Lin,et al.  Therapeutic protein-polymer conjugates: advancing beyond PEGylation. , 2014, Journal of the American Chemical Society.

[10]  Jinchao Zhang,et al.  Ultrasmall Gold Nanoparticles as Carriers for Nucleus-Based Gene Therapy Due to Size-Dependent Nuclear Entry , 2014, ACS nano.

[11]  Tianjiao Ji,et al.  Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. , 2014, ACS nano.

[12]  R. Jain,et al.  Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo. , 2013, Angewandte Chemie.

[13]  Jinchao Zhang,et al.  Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. , 2013, Cancer research.

[14]  Xiu Shen,et al.  In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. , 2012, Biomaterials.

[15]  Tuo Wei,et al.  Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. , 2012, ACS nano.

[16]  Dan Peer,et al.  Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.

[17]  A. Baas,et al.  FDA-approved poly(ethylene glycol)–protein conjugate drugs , 2011 .

[18]  Jie Zheng,et al.  Luminescent gold nanoparticles with efficient renal clearance. , 2011, Angewandte Chemie.

[19]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[20]  Manuela Semmler-Behnke,et al.  Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. , 2010, Biomaterials.

[21]  T. Niidome,et al.  The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[23]  Warren C W Chan,et al.  Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.

[24]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[25]  Subra Suresh,et al.  Size‐Dependent Endocytosis of Nanoparticles , 2009, Advanced materials.

[26]  James E Hutchison,et al.  Toward greener nanosynthesis. , 2007, Chemical reviews.

[27]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[29]  Ming Zheng,et al.  Ethylene glycol monolayer protected nanoparticles for eliminating nonspecific binding with biological molecules. , 2003, Journal of the American Chemical Society.

[30]  R. Murray,et al.  Monolayer-protected cluster molecules. , 2000, Accounts of chemical research.